Guardian Pharmacy Services, Inc. earnings per share and revenue
On Nov 10, 2025, GRDN reported earnings of 0.15 USD per share (EPS) for Q3 25, missing the estimate of 0.17 USD, resulting in a -13.49% surprise. Revenue reached 377.43 million, compared to an expected 361.23 million, with a 4.48% difference. The market reacted with a +5.04% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analysts forecast an EPS of 0.22 USD, with revenue projected to reach 396.93 million USD, implying an increase of 46.67% EPS, and increase of 5.17% in Revenue from the last quarter.
FAQ
What were Guardian Pharmacy Services, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Guardian Pharmacy Services, Inc. reported EPS of $0.15, missing estimates by -13.49%, and revenue of $377.43M, 4.48% above expectations.
How did the market react to Guardian Pharmacy Services, Inc.'s Q3 2025 earnings?
The stock price moved up 5.04%, changed from $29.75 before the earnings release to $31.25 the day after.
When is Guardian Pharmacy Services, Inc. expected to report next?
The next earning report is scheduled for Mar 24, 2026.
What are the forecasts for Guardian Pharmacy Services, Inc.'s next earnings report?
Based on 6
analysts, Guardian Pharmacy Services, Inc. is expected to report EPS of $0.22 and revenue of $396.93M for Q4 2025.